Role of Shodhan and Shaman Karma for the management of Psoriasis- A Case Report

  • Dr. Narayan Pandey Department of Agadatantra, National Institute of Ayurveda,Rajasthan, India.
  • Dr. Harish Bhakuni Department of Kayachikitsa, National Institute of Ayurveda,Rajasthan, India.
  • Dr. Vikas Kumar Vikrant Department of Kayachikitsa, National Institute of Ayurveda,Rajasthan, India.
  • Dr. Pooja Verma Department of Agadatantra, National Institute of Ayurveda,Rajasthan, India.
  • Dr. Shankar Gautam Department of Kayachikitsa, National Institute of Ayurveda,Rajasthan, India
Keywords: Ekakustha, Psoriasis, Shamana, Shodhan

Abstract

Introduction: Psoriasis is one of the most common dermatologic diseases affecting up to 1% of the world population. It is characterized by erythematous sharply demarcated papules and rounded plaques, covered by silvery micaceous scale. Psoriasis can be correlated with Ekakushtain Ayurveda. The prevalence of psoriasis is 2-3 percentages where in India, the prevalence of psoriasis varies from 0.44% to 2.88% worldwide.Ayurveda has adapted various kinds of treatment modalities. Generally, for psoriasis, SanshodhanKarma (Purification therapy) and SamshamanaKarma (Pacification) have been used. 

Case Report: In this case study, a patient who had already been diagnosed with psoriasis, with the symptoms of red patches over the trunk region for 2.5 years and minute whitish silvery scaly over the red patches had been treated with Vamana,Virechana procedure along with Shaman Karma with Ayurvedic remedies.

Results: On clinical examinations, he had multiple redness maculo-papular with silvery scaly over the trunk and back with slightly itching sensation along with absence of sweating on affected areas. His problem got aggravated day by day. Then Shodhan Karma (Vamana and Virechana Karma) was started. For which Deepan, Paachan, Snehan Paan followed by Sarvanga Abhyanga Karma has accustomed. Then Vamana Karma, Samsarjhan Kram was done accordingly. Then he had taken some formulations of Ayurvedic medicine. Thus, After the completion of the course of intervention, he got complete relief from all the symptoms.

Conclusion: Psoriasis can be treated significantly by multi-modal Ayurveda treatment like, ShodhanaKarma (purification), ShamanKarma.

References

Armstrong AW, Reich K, Foley P, Han C, Song M, Shen YK, You Y, Papp KA. Improvement in patient-reported outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with guselkumab in moderate-to-severe plaque psoriasis: results from the phase III VOYAGE 1 and VOYAGE 2 studies. American journal of clinical dermatology. 2019 Feb 13;20(1):155-64.

Gupta R, Debbaneh MG, Liao W. Genetic Epidemiology of Psoriasis. Curr Dermatol Rep. 2014 Mar;3(1):61-78. doi: 10.1007/s13671-013-0066-6. PMID: 25580373; PMCID: PMC4285384

Sukla V, Tripathi RD. Charak Samhita. Part 2. Chikitsasthan, 7/21.Delhi: Chaukhamba Sanskrit Pratishthan; 2012. p. 184.

Sukla V, Tripathi RD. Charak Samhita. Part 2. Chikitsasthan, 7/29.Delhi: Chaukhamba Sanskrit Pratishthan; 2012. p. 185.

Sukla V, Tripathi RD. Charak Samhita. Part 2. Nidansthan, 5/3.Delhi: Chaukhamba Sanskrit Pratishthan; 2012. p. 513

Sukla V, Tripathi RD. Charak Samhita. Part 2. Chikitsasthan, 7/41-42.Delhi: Chaukhamba Sanskrit Pratishthan; 2012. p. 186.

Sukla V, Tripathi RD. Charak Samhita. Part 2. Chikitsasthan, 7/58.Delhi: Chaukhamba Sanskrit Pratishthan; 2012. p. 188.

Louden BA, Pearce DJ, Lang W, Feldman SR. A Simplified Psoriasis Area Severity Index (SPASI) for rating psoriasis severity in clinic patients. Dermatology online journal. 2004;10(2).

Sukla V, Tripathi RD. Charak Samhita. Part 2. Chikitsasthan, 7/41.Delhi: Chaukhamba Sanskrit Pratishthan; 2012. p. 186.

Sukla V, Tripathi RD. Charak Samhita. Part 2. Chikitsasthan, 7/39.Delhi: Chaukhamba Sanskrit Pratishthan; 2012. p. 186.

Shastri.A. Sushruta Samhita .part1. Chikitsasthan,36/52. Varanasi: Chaukhamba Sanskrit Sansthan;2019. p. 197

Sukla V, Tripathi RD. Charak Samhita. Part 1. Sutrasthan, 13/91-92.Delhi: Chaukhamba Sanskrit Pratishthan; 2012. p. 209

Sharma P.V. DravyagunaVijnana, part 2. Varanasi: Chaukhamba Bharati Academy;2009. p. 376

Sharma P.V, DragyagunaVijnana, part 2. Varanasi: Chaukhamba Bharati Academy;2009. p. 421

Sukla V, Tripathi RD. Charak Samhita. Part 2. Chikitsasthan, 1/7-8.Delhi: Chaukhamba Sanskrit Pratishthan; 2012. p. 5.

Sharma P.V, DragyagunaVijnana, part 2. Varanasi: Chaukhamba Bharati Academy;2009. p. 421

Sharma P.V. DravyagunaVijnana, part 2. Varanasi: Chaukhamba Bharati Academy;2009. p. 800

Chunekar K.C. Bhavaprakash Nighantu of Sri Bhavamishra. HaritkyadiVarga 1/191. Varanasi:Chaukhamba Bharati Academy;2020.p.107

Tripathi B. Sarngadhara Samhita. Madhyam Khanda 7/70-81. Varanasi: ChaukhambaSurbharti Prakashan;2020.p. 136

Tripathi B,Sarngadhara Samhita, Madhyam Khanda 6/13-14.Varanasi:Chaukhamba Surbharti Prakashan;2020.p. 117

Tripathi B.Sarngadhara Samhita. Madhyam Khanda 6/7. Varanasi: ChaukhambaSurbhartiPrakashan; 2020.p. 117

NathusinghaThakur.Rasa tantra saar and Siddhaprayogasangraha. 27th ed. part 1, Rajasthan:KrishnagopalAyurved Bhawan;2016. p. 442.

Tripathi Hariharprasad. Madanpal Nighantu. AbhayadiVarga, Varanasi: Chaukhamba Krishnadas Academy;2018. p. 30.

Published
2021-12-30
How to Cite
1.
Pandey N, Bhakuni H, Vikrant VK, Verma P, Gautam S. Role of Shodhan and Shaman Karma for the management of Psoriasis- A Case Report. IJATM [Internet]. 2021Dec.30 [cited 2022May27];3(5):35-1. Available from: https://ijatm.org/index.php/ijatm/article/view/123
Issue
Vol 3 No 5 (2021): December
Section
CLINICAL CASE REPORT

Copyright (c) 2021 International Journal of Ayurveda and Traditional Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

IJATM  follows the following Terms and License of the manuscript under Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) where Author and Journal are can  Share — copy and redistribute the material in any medium or format and Adapt — remix, transform, and build upon the material, and it is Non-Commercial.